- Home
- HBIO vs NYC Comparison
HBIO vs NYC Comparison
Compare HBIO & NYC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HBIO
- NYC
- Stock Information
- Founded
- HBIO 1901
- NYC 2013
- Country
- HBIO United States
- NYC United States
- Employees
- HBIO N/A
- NYC N/A
- Industry
- HBIO Biotechnology: Laboratory Analytical Instruments
- NYC Real Estate
- Sector
- HBIO Industrials
- NYC Finance
- Exchange
- HBIO Nasdaq
- NYC Nasdaq
- Market Cap
- HBIO 24.6M
- NYC 25.4M
- IPO Year
- HBIO 2000
- NYC N/A
- Fundamental
- Price
- HBIO $0.76
- NYC $7.35
- Analyst Decision
- HBIO Buy
- NYC
- Analyst Count
- HBIO 3
- NYC 0
- Target Price
- HBIO $2.50
- NYC N/A
- AVG Volume (30 Days)
- HBIO 18.9M
- NYC 4.2K
- Earning Date
- HBIO 11-06-2025
- NYC 11-19-2025
- Dividend Yield
- HBIO N/A
- NYC N/A
- EPS Growth
- HBIO N/A
- NYC N/A
- EPS
- HBIO N/A
- NYC N/A
- Revenue
- HBIO $87,371,000.00
- NYC $51,688,000.00
- Revenue This Year
- HBIO N/A
- NYC $8.40
- Revenue Next Year
- HBIO $7.02
- NYC $1.62
- P/E Ratio
- HBIO N/A
- NYC N/A
- Revenue Growth
- HBIO N/A
- NYC N/A
- 52 Week Low
- HBIO $0.28
- NYC $7.20
- 52 Week High
- HBIO $2.38
- NYC $16.30
- Technical
- Relative Strength Index (RSI)
- HBIO 66.85
- NYC 36.73
- Support Level
- HBIO $0.56
- NYC $7.35
- Resistance Level
- HBIO $0.74
- NYC $8.27
- Average True Range (ATR)
- HBIO 0.08
- NYC 0.44
- MACD
- HBIO 0.01
- NYC 0.01
- Stochastic Oscillator
- HBIO 95.47
- NYC 35.48
About HBIO Harvard Bioscience Inc.
Harvard Bioscience Inc is a developer, manufacturer, and seller of technologies, specialized products and services that enable fundamental research, pharmaceutical and therapy discovery, bioproduction, and pre-clinical testing for drug development. Its primary focus is scientific instruments used to advance life sciences and research. With operations in North America, Europe and china it sells through a combination of direct and distribution channels to customers around the world. The product brands of the company include Harvard Apparatus, DSI, Buxco, Biochrom, BTX, Heka, Hugo Sachs, and Panlab. The majority of its revenue comes from the United States.
About NYC American Strategic Investment Co.
American Strategic Investment Co is an externally managed company that currently owns a portfolio of commercial real estate located within the five boroughs of New York City, majorly Manhattan. The Company's real estate assets consist of office properties and certain real estate assets that accompany office properties, including retail spaces and amenities.